fbpx

Better Access to Liver Cancer Medicines

Posted 05 October, 2020
Other News
Better liver health campaign evokes public action against hepatitis
< 1 min read
Posted 28 July, 2022

Hepatitis Queensland (HQ) is calling on Queenslanders to come together to eliminate viral hepatitis this…

Read Article
Today is 2022 International NASH Day!
< 1 min read
Posted 9 June, 2022

International NASH Day is a public education campaign to raise visibility and urgency around fatty…

Read Article
Severe hepatitis in children
< 1 min read
Posted 9 May, 2022

Recent Australian media articles have reported cases of severe hepatitis (inflammation of the liver) of…

Read Article

Australians living with liver cancer will soon have new treatment options with changes to the Pharmaceutical Benefits Scheme (PBS) coming into effect.

The changes include better access to treatments for patients with advanced unresectable hepatocellular carcinoma. Unresectable hepatocellular carcinoma is the most common form of liver cancer, which often occurs in people with other chronic liver diseases. It also has one of the lowest survival rates of all cancer types.

From 1 November, more than 500 patients per year could benefit from PBS listing of this treatment, which would otherwise cost more than $170,000 per course. Australia will be the first country in the world to have this combination treatment publically funded for this type of liver cancer.


Related News
Read Article
Read Article
Read Article

This website may contain the names and images of Aboriginal and Torres Strait Islander people who have passed on.

CLOSE